PHARMA WORLD: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA WORLD
Largest movements
- Tangible fixed assets +€222,040
up €222,040 (+32.6%), from €681,658 to €903,697
of which Land and buildings: +€239,185
- Receivables within one year -€108,705
down €108,705 (-51.3%), from €211,908 to €103,203
of which Other amounts receivable: -€94,591
- Other debts +€258,771
up €258,771 (+71.3%), from €362,791 to €621,562
- Debts after one year -€140,116
down €140,116 (-20.4%), from €685,546 to €545,431
- Reserves +€44,857
up €44,857 (+9.9%), from €453,052 to €497,909
of which Distributable reserves: +€44,857
- Trade debts -€30,335
down €30,335 (-84.4%), from €35,954 to €5,620
- Gross operating margin +€31,946
up €31,946 (+19.2%), from €166,252 to €198,198
- Financial charges +€30,329
up €30,329 (+97.8%), from €30,995 to €61,324
- Depreciation +€28,605
up €28,605 (+72.4%), from €39,497 to €68,102
- Taxes -€5,067
down €5,067 (-18.8%), from €26,949 to €21,882
- Financial income -€4,384
down €4,384 (-69.3%), from €6,328 to €1,944
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,746,627 | €1,875,873 | +€129,246 | +7.4% |
| Fixed assets | 21/28 | €1,502,087 | €1,724,127 | +€222,040 | +14.8% |
| Tangible fixed assets | 22/27 | €681,658 | €903,697 | +€222,040 | +32.6% |
| Land and buildings | 22 | €625,890 | €865,075 | +€239,185 | +38.2% |
| Furniture and vehicles | 24 | €55,767 | €38,623 | -€17,145 | -30.7% |
| Financial fixed assets | 28 | €820,430 | €820,430 | = | 0.0% |
| Current assets | 29/58 | €244,540 | €151,746 | -€92,794 | -37.9% |
| Amounts receivable within one year | 40/41 | €211,908 | €103,203 | -€108,705 | -51.3% |
| Trade receivables | 40 | €14,349 | €235 | -€14,114 | -98.4% |
| Other amounts receivable | 41 | €197,559 | €102,968 | -€94,591 | -47.9% |
| Cash at bank and in hand | 54/58 | €31,082 | €47,143 | +€16,060 | +51.7% |
| Deferred charges and accrued income | 490/1 | €1,550 | €1,401 | -€149 | -9.6% |
| Total equity and liabilities | 10/49 | €1,746,627 | €1,875,873 | +€129,246 | +7.4% |
| Equity | 10/15 | €471,652 | €516,509 | +€44,857 | +9.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €453,052 | €497,909 | +€44,857 | +9.9% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €453,052 | €497,909 | +€44,857 | +9.9% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €1,274,976 | €1,359,365 | +€84,389 | +6.6% |
| Amounts payable after more than one year | 17 | €685,546 | €545,431 | -€140,116 | -20.4% |
| Financial debts | 170/4 | €685,546 | €545,431 | -€140,116 | -20.4% |
| Amounts payable within one year | 42/48 | €588,613 | €808,947 | +€220,334 | +37.4% |
| Current portion of amounts payable after more than one year | 42 | €134,376 | €140,116 | +€5,740 | +4.3% |
| Trade debts | 44 | €35,954 | €5,620 | -€30,335 | -84.4% |
| Suppliers | 440/4 | €35,954 | €5,620 | -€30,335 | -84.4% |
| Taxes, remuneration and social security | 45 | €55,492 | €41,649 | -€13,843 | -24.9% |
| Taxes | 450/3 | €54,942 | €41,649 | -€13,293 | -24.2% |
| Remuneration and social security | 454/9 | €550 | €0 | -€550 | -100.0% |
| Other amounts payable | 47/48 | €362,791 | €621,562 | +€258,771 | +71.3% |
| Accrued charges and deferred income | 492/3 | €816 | €4,988 | +€4,171 | +510.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €39,497 | €68,102 | +€28,605 | +72.4% |
| Other operating charges | 640/8 | €5,144 | €3,977 | -€1,167 | -22.7% |
| Gross operating margin | 9900 | €166,252 | €198,198 | +€31,946 | +19.2% |
| Operating profit (loss) | 9901 | €121,611 | €126,119 | +€4,508 | +3.7% |
| Financial income | 75/76B | €6,328 | €1,944 | -€4,384 | -69.3% |
| Recurring financial income | 75 | €6,328 | €1,944 | -€4,384 | -69.3% |
| Financial charges | 65/66B | €30,995 | €61,324 | +€30,329 | +97.8% |
| Recurring financial charges | 65 | €30,995 | €61,324 | +€30,329 | +97.8% |
| Profit (loss) for the period before taxes | 9903 | €96,943 | €66,738 | -€30,205 | -31.2% |
| Income taxes | 67/77 | €26,949 | €21,882 | -€5,067 | -18.8% |
| Profit (loss) for the period | 9904 | €69,995 | €44,857 | -€25,138 | -35.9% |
| Profit (loss) for the period to be appropriated | 9905 | €69,995 | €44,857 | -€25,138 | -35.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.